UNC13A

This gene encodes a member of the UNC13 family.[5] UNC13A plays a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway. It is involved in neurotransmitter release by acting in synaptic vesicle priming prior to vesicle fusion and participates in the activity-dependent refilling of readily releasable vesicle pool. In Drosophila melanogaster, the protein has been shown to define the vesicle release site by regulating the coupling distance between synaptic vesicles and calcium channels in cooperation with another isoform, UNC13B.[6] It is particularly important in most glutamatergic-mediated synapses as well as GABA-mediated synapses. It plays a role in dendrite formation by melanocytes and in secretory granule priming in insulin secretion.[7]

Several conserved domains have been found in UNC13A. These conserved domains include three C2 domains. One C2 domain is centrally located, another is at the carboxyl end, and there is a third. In addition, there is one C1 domain, as well as Munc13 homology domains 1 (MHD1) and 2 (MHD2).[7][8]

UNC13A is localized to the active zone of presynaptic density. It is translocated to the plasma membrane in response to phorbol ester binding.[7]

UNC13A has been shown to interact with:

• STX1A,[7]
• STX1B1,[7]
• DOC2A,[7]
• BSN,[7]
• RIMS1,[7]
• RIMS2,[7]
• ERC2,[7] and
• RAB3A.[7]

Single nucleotide polymorphisms in this gene may be associated with sporadic amyotrophic lateral sclerosis.[9][10][11][12] This single nucleotide polymorphism has been discovered on chromosome 19. This variation of the single nucleotide involving UNC13A has also been implicated in frontotemporal dementia (FTD). Pathology involving TDP-43 is a result of the single nucleotide polymorphisms in both ALS and FTD.[13] This gene has also been associated with Alzheimer's Disease (AD).[14]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.